Streetbeat News

Analyst Ratings

ALB

APTV

BIO

FSLR

HAL

MRO

NEM

UAL

WBD

The S&P 500 index has seen a 20% gain in the past three months, driven by AI, earnings optimism, and expected rate cuts. Investors are evaluating S&P 500 stocks for upside potential based on Wall Street analysts' price targets. Warner Bros. Discovery (WBD), First Solar (FSLR), and Marathon Oil (MRO) are among the top stocks with over 40% projected upside. Other notable mentions include United Airlines (UAL), Bunge Global (BG), Albemarle Corporation (ALB), Newmont Corporation (NEM), Aptiv PLC (APTV), Bio-Rad Laboratories (BIO), and Halliburton Company (HAL).

Portfolio Pulse from Piero Cingari

January 23, 2024 | 6:12 pm

ASML

GFS

INTC

NVDA

NXPI

QCOM

SOXX

TER

WDC

Cantor Fitzgerald initiated coverage on the semiconductor industry, predicting a 14% average upside for 18 stocks in 2024. Top picks include NVIDIA, Western Digital, ASML Holding, NXP Semiconductors, and GlobalFoundries, with projected upsides between 21% and 36%. Micron Technology, AMD, and Marvell Technology also have over 15% upside potential. However, Qualcomm, Teradyne, and Intel are rated neutral and expected to underperform. The semiconductor industry is in a cyclical recovery, with AI, PC/Smartphones, and Data Center/Networking sectors poised for gains. Cantor analyst C.J. Muse forecasts 18% growth in semiconductor revenues for 2024, with potential to exceed 20%.

Portfolio Pulse from Surbhi Jain

January 23, 2024 | 6:04 pm

RUN

Sunrun (NASDAQ:RUN) has been the subject of diverse analyst ratings over the past three months, with 13 analysts offering a range of opinions. The average 12-month price target is $21.46, with a high of $35.00 and a low of $12.00, marking an 8.91% decrease in the average target. Recent actions include both raised and lowered price targets and ratings, reflecting dynamic market conditions and company performance. Sunrun's financials show a -10.88% revenue decline over 3 months, a net margin of -189.9%, an ROE of -17.52%, an ROA of -5.28%, and a high debt-to-equity ratio of 1.9.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:01 pm

ZUO

In the last three months, 4 analysts have provided ratings on Zuora (NYSE:ZUO), with all maintaining a bullish stance. The average 12-month price target is $14.5, representing a 45% increase from the previous target of $10. Zuora's financial performance shows positive revenue growth, a strong net margin, and an excellent ROE and ROA, but a high debt-to-equity ratio. Analysts from Goldman Sachs, Needham, and Canaccord Genuity have recently updated their ratings and price targets for ZUO.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:01 pm

MSFT

QCOM

On CNBC's Halftime Report, the final trades segment featured stock recommendations for Microsoft (MSFT) and QUALCOMM (QCOM).

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 6:00 pm

ADM

Archer-Daniels Midland (NYSE:ADM) has been the subject of 10 analyst ratings over the past three months, with a shift towards a more bearish sentiment. The average 12-month price target has been reduced by 27.15%, with the current average at $70.3. Analysts from firms including Goldman Sachs, Stifel, Barclays, Roth MKM, BMO Capital, Baird, UBS, and Morgan Stanley have lowered their price targets. ADM's financial performance shows a decline in revenue growth by -12.11% over the past 3 months, but it maintains strong net margin, ROE, and ROA figures, and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:00 pm

SEDG

SolarEdge Technologies (NASDAQ:SEDG) has received mixed ratings from 21 financial analysts, with a current average 12-month price target of $79.28, down 32.82% from the previous $118.01. Ratings range from 'Buy' to 'Sell', with recent actions including both upgrades and downgrades. The company's financial performance shows a -13.32% decline in revenue growth, a net margin of -8.43%, ROE of -2.44%, ROA of -1.31%, and a debt-to-equity ratio of 0.29.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:00 pm

BofA Securities analyst Craig Siegenthaler provided insights on Blackstone Inc's (NYSE:BX) upcoming Q4 FY23 earnings, expecting in-line results but an improving outlook. Siegenthaler anticipates bullish trends in fundraising, investing, and realizations, despite recent adjustments due to negative returns in Blackstone's real estate funds. The near-term EPS revisions are not expected to significantly impact long-term EPS for 2025-26. Despite potential negative reactions to quarterly performance, the analyst foresees an improving trajectory by March and an end to BREIT limits by mid-2024, leading to a significant sales increase. Siegenthaler estimates EPS of $5.09 for FY24 and $6.48 for FY25, maintaining a Buy rating and a price target of $135 for BX stock, which he believes is undervalued. BX shares were down 1.9% to $118.65.

Portfolio Pulse from Lekha Gupta

January 23, 2024 | 5:58 pm

ALC

CZMWY

Bernstein analyst Susannah Ludwig has initiated coverage on ophthalmology companies, recommending Alcon AG (NYSE:ALC) with an Outperform rating and a price target of $94.03, while giving Carl Zeiss Meditec AG (OTC:CZMWY) an Underperform rating with a price target of $82.31. Ludwig highlights the importance of innovation in the ophthalmology market, which is valued at $34 billion with mid-single digit growth rates. Alcon is noted for its significant R&D spending, which is 1.9 times higher than its next competitor, while Zeiss, though leading in digital, must maintain high R&D spending to stay competitive. Shares of Alcon and Carl Zeiss Meditec declined by 2.34% and 0.95%, respectively, at the time of publication.

Portfolio Pulse from Priya Nigam

January 23, 2024 | 5:47 pm

FANG

Stifel analyst Derrick Whitfield has maintained a Buy rating on Diamondback Energy (NASDAQ:FANG) but has reduced the price target from $194 to $192.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:38 pm